Venrock Healthcare Capital Partners III, L.P. Insider Trading Activity

Average Profitability
28.03%
Insider Buys Quantity
36
Insider Buys Sum
$42.14M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Venrock Healthcare Capital Partners III, L.P.

Biography of Venrock Healthcare Capital Partners III, L.P.

No biography is available at this moment.

2025-02-14PurchaseOruka Therapeutics, Inc.
ORKA
10 percent owner
88,794
0.0994%
$11.44$1.02M+32.42%
2025-02-13PurchaseOruka Therapeutics, Inc.
ORKA
10 percent owner
14,950
0.017%
$11.63$173,869+29.48%
2025-02-12PurchaseOruka Therapeutics, Inc.
ORKA
10 percent owner
8,971
0.0104%
$11.86$106,396+24.68%
2025-02-11PurchaseOruka Therapeutics, Inc.
ORKA
10 percent owner
9,593
0.0103%
$10.95$105,043+34.7%
2025-02-10PurchaseOruka Therapeutics, Inc.
ORKA
10 percent owner
574
0.0006%
$10.90$6,257+34.74%
2020-06-15PurchaseAltimmune, Inc.
ALT
10 percent owner
1.5M
8.2332%
$7.54$11.31M+74.15%
2020-05-28PurchaseAltimmune, Inc.
ALT
10 percent owner
201,474
1.2009%
$8.72$1.76M+62.22%
2020-05-27PurchaseAltimmune, Inc.
ALT
10 percent owner
402,162
2.1415%
$7.71$3.1M+64.03%
2020-05-26PurchaseAltimmune, Inc.
ALT
10 percent owner
700,000
4.3422%
$9.34$6.54M+57.6%
Total: 9
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.